Holen Sie sich die Stockscreener-App
55.14
0.13%
0.07
Vorhandelsmarkt:
55.15
0.010
+0.02%
Schlusskurs vom Vortag:
$55.07
Offen:
$55
24-Stunden-Volumen:
689.38K
Relative Volume:
0.67
Marktkapitalisierung:
$1.50B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.66%
1M Leistung:
+20.47%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$53.97
$55.96
1-Wochen-Bereich:
$53.97
$58.11
52-Wochen-Spanne:
$33.42
$62.18
Hinge Health Inc Stock (HNGE) Company Profile
Firmenname
Hinge Health Inc
Sektor
Branche
Telefon
415-689-8429
Adresse
455 MARKET STREET, SAN FRANCISCO
Vergleichen Sie HNGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
55.14 | 4.63B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
286.54 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
76.30 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.08 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.33 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.16 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-06-16 | Eingeleitet | Barclays | Overweight |
| 2025-06-16 | Eingeleitet | BofA Securities | Buy |
| 2025-06-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-06-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-06-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-06-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-06-16 | Eingeleitet | Needham | Buy |
| 2025-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2025-06-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-06-16 | Eingeleitet | Raymond James | Outperform |
| 2025-06-16 | Eingeleitet | Stifel | Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Hinge Health Inc Aktie (HNGE) Neueste Nachrichten
Piper Sandler maintains Overweight rating on Hinge Health stock, cites strong technology moats - Investing.com
Hinge Health (NYSE:HNGE) Shares Gap DownHere's What Happened - MarketBeat
Hinge Health (NYSE:HNGE) Reaches New 52-Week HighShould You Buy? - MarketBeat
Hinge Health Announces Early Share Lock-Up Release - MSN
Hinge Health’s Growth Stands Out In Digital Health Market - Finimize
Hinge Health (NYSE:HNGE) Stock Price Up 5.7%Time to Buy? - MarketBeat
Piper Sandler raises Hinge Health stock price target to $70 on strong outlook - Investing.com
Hinge Health’s Strategic Initiatives and Growth Potential Drive Buy Rating - TipRanks
CCORF Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $61 - 富途牛牛
Hinge Health (NYSE:HNGE) Trading Down 7.1%Here's What Happened - MarketBeat
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail
Baron Small Cap Fund is Excited to Invest in Hinge Health (HNGE). Here’s Why - Insider Monkey
Is hnge a buy sell or hold - AInvest
Hinge Health (NYSE:HNGE) Price Target Raised to $65.00 - MarketBeat
Hinge Health (NYSE:HNGE) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Hinge Health (NYSE:HNGE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
Hinge Health (NYSE:HNGE) Given New $60.00 Price Target at Evercore ISI - MarketBeat
Hinge Health (NYSE:HNGE) Price Target Raised to $59.00 - MarketBeat
Morgan Stanley Raises Hinge Health (NYSE:HNGE) Price Target to $57.00 - MarketBeat
Bank of America Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health, Inc. Class A Common Stock (NYSE:HNGE) Stock Quote - FinancialContent
Hinge Health shares fall 1.26% intraday as Trump's import taxes raise economic concerns. - AInvest
Brokerages Set Hinge Health Inc. (NYSE:HNGE) Price Target at $49.86 - Defense World
Hinge Health Inc. (NYSE:HNGE) Given Average Rating of "Buy" by Analysts - MarketBeat
Morgan Stanley Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - Defense World
Barclays Boosts Hinge Health (NYSE:HNGE) Price Target to $62.00 - MarketBeat
Hinge Health price target raised to $62 from $48 at Truist - Yahoo Finance
Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald - TipRanks
Hinge Health (NYSE:HNGE) Sets New 52-Week High on Analyst Upgrade - Defense World
Hinge Health: Is It Too Late to Buy? - timothysykes.com
Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective - TipRanks
Hinge Health shares rise 23.34% intraday after RBC raised its price target to $60. - AInvest
TR | OpenAI4o Initiates Hinge Health(HNGE.US) With Hold Rating, Announces Target Price $52 - 富途牛牛
Hinge Health's Q2 Earnings Surge: A Case Study in Long-Term Value Creation Post-IPO - AInvest
Hinge Health Raises PT to $61 at Canaccord Genuity Maintains Buy Rating - AInvest
Hinge Health's Q2 Earnings: A Strategic Bet on AI-Driven Healthcare Automation - AInvest
Hinge Health Q2 beat: 'Long-term' thinking is key, CEO says - Yahoo Finance
Hinge Health's AI-Driven Surge: Redefining Digital Healthcare Profitability Post-IPO - AInvest
Hinge Health beats Wall Street expectations on revenue in first public earnings - Healthcare Dive
Hinge Health price target raised to $63 from $55 at Stifel - TipRanks
Hinge Health Climbs Amidst Strategic Acquisitions and Expanding Horizons - StocksToTrade
Hinge Health price target raised to $59 from $47 at Needham - TipRanks
Elevating Dynamics: Hinge Health’s Strategic Moves Stir Market Pattens - timothysykes.com
Hinge Health's Post-IPO Surge: Clinical Excellence and Employer Adoption Fuel a New Era in Digital MSK Care - AInvest
Hinge Health Gains in Market Debut, Providing a Favorable Sign for IPOs -- Update - 富途牛牛
Hinge Health Soars 22.7% on Q2 Earnings Surge: Can This AI-Powered Healthcare Play Sustain Momentum? - AInvest
Why are Hinge Health’s Shares Surging in Premarket Trading Today? - Tokenist
RBC Raises Price Target on Hinge Health to $60 From $45, Keeps Outperform Rating - MarketScreener
Hinge Health's Post-IPO Surge: A Test of Fundamentals in the Digital Therapeutics Gold Rush - AInvest
Hinge Health price target raised to $57 from $46 at Morgan Stanley - TipRanks
Finanzdaten der Hinge Health Inc-Aktie (HNGE)
Es liegen keine Finanzdaten für Hinge Health Inc (HNGE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):